Shaping Portfolios: The Role of Patient Engagement in Impact Assessment

Patient Engagement has emerged as a powerful strategy in de-risking investment by grounding innovations in real-world patient needs, while also unlocking opportunities for stronger market impact and resilience. This meetings is designed for investors and industry leaders seeking to enhance the strategic impact of their life sciences investments through Patient Engagement. Participants will gain insights into how Patient Engagement can help build long-term value by aligning company goals with patient-centric outcomes. 

The session will address key challenges in implementing Patient Engagement as an impact accelerator. We will explore the role of metrics and active ownership as a structured solution, providing transparency, accountability, and a framework for demonstrating Patient Engagement’s contribution to business and societal impact. 

Stephanie Mooij (Gilde Healthcare) introduced Patient Engagement metrics in their ESG/Impact questionnaire and will share practical insights and experiences, illustrating how they’ve tapped into Patient Engagement to drive impact in their portfolio.

Join us to discover how integrating Patient Engagement can enhance the value, market positioning, and long-term sustainability of your investments in the life sciences sector, and to collectively identify accelerators and strategic priorities to elevate Patient Engagement as a critical impact lever for life sciences companies.